Picton Mahoney Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Sell
32,987
-8,385
-20% -$8.5M 0.22% 70
2025
Q4
$44.5M Buy
41,372
+12,119
+41% +$11.6M 0.34% 51
2025
Q3
$22.3M Sell
29,253
-14,470
-33% -$10.8M 0.2% 89
2025
Q2
$34.1M Buy
43,723
+6,640
+18% +$5.16M 0.35% 55
2025
Q1
$30.6M Buy
37,083
+5,220
+16% +$4.34M 0.53% 23
2024
Q4
$24.6M Sell
31,863
-9,555
-23% -$7.91M 0.5% 32
2024
Q3
$36.7M Sell
41,418
-4,829
-10% -$4.34M 1.2% 11
2024
Q2
$41.9M Sell
46,247
-2,020
-4% -$1.62M 1.63% 6
2024
Q1
$37.5M Sell
48,267
-959
-2% -$682K 1.12% 12
2023
Q4
$28.7M Sell
49,226
-12,633
-20% -$7.37M 0.78% 15
2023
Q3
$33.2M Sell
61,859
-8,288
-12% -$4.27M 0.99% 16
2023
Q2
$32.9M Sell
70,147
-8,599
-11% -$3.61M 1.42% 9
2023
Q1
$27M Sell
78,746
-165
-0.2% -$55.6K 1.2% 8
2022
Q4
$28.9M Sell
78,911
-2,762
-3% -$979K 1.36% 6
2022
Q3
$26.4M Sell
81,673
-8,292
-9% -$2.63M 0.95% 12
2022
Q2
$29.2M Sell
89,965
-6,352
-7% -$1.91M 1.11% 4
2022
Q1
$27.6M Sell
96,317
-7,658
-7% -$1.97M 0.98% 9
2021
Q4
$28.7M Buy
103,975
+8,000
+8% +$2.03M 0.7% 11
2021
Q3
$22.2M Buy
95,975
+2,970
+3% +$733K 0.82% 19
2021
Q2
$21.3M Buy
93,005
+21,155
+29% +$4.25M 0.62% 29
2021
Q1
$13.4M Buy
+71,850
New +$14.1M 0.64% 40
2020
Q2
Sell
-8,255
Closed -$1.15M 336
2020
Q1
$1.15M Buy
+8,255
New +$1.13M 0.06% 204
2013
Q4
Sell
-204,800
Closed -$10.3M 371
2013
Q3
$10.3M Buy
+204,800
New +$10.7M 0.68% 52

Other funds holding LLY

Picton Mahoney Asset Management's LLY Position: Q1 2026 in Review

Picton Mahoney Asset Management reduced its Eli Lilly (LLY) stake by 20% in Q1 2026, selling an estimated $8.5M and leaving 32,987 shares worth $30.3M. The position accounts for 0.22% of the portfolio, ranked #70.

Picton Mahoney Asset Management first reported a position in LLY in Q3 2013 and has held it in 23 quarters since. The position peaked at $44.5M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Picton Mahoney Asset Management held 32,987 shares of Eli Lilly worth $30.3M as of Q1 2026.
  • Picton Mahoney Asset Management sold 8,385 Eli Lilly shares in Q1 2026, an estimated $8.5M.
  • Eli Lilly made up 0.22% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #70 holding.
  • Picton Mahoney Asset Management first reported a position in Eli Lilly in Q3 2013 and has held it in 23 quarters since.
  • Picton Mahoney Asset Management's Eli Lilly position peaked at $44.5M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.